Trade Summary

2 months ago, Arch Venture Partners Xii, LLC, serving as 10% owner at Neumora Therapeutics, Inc. (NMRA), purchased 1,915,700 shares at $2.61 per share, for a total transaction value of $4,999,977.00. Following this transaction, Arch Venture Partners Xii, LLC now holds 33,847,838 shares of NMRA.

This purchase represents a 6.00% increase in Arch Venture Partners Xii, LLC's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, October 27, 2025 and publicly disclosed via SEC Form 4 filing on Wednesday, October 29, 2025, 2 days after the trade was made.

Neumora Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.